Human GloLIVE TRA-1-60(R) NorthernLights™ NL557-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # NLLC4770R
Key Product Details
Summary
To detect TRA-1-60(R) expression in live cells by immunocytochemical staining.
Why confirm marker expression in live cells before colony selection?
Maintaining pluripotent human embryonic stem cells and deriving induced pluripotent stem cells require colony selection and cell expansion. Picking colonies that contain pluripotent stem cells is typically achieved by manually analyzing colony morphology. Unfortunately, this critical process is time-consuming and labor-intensive.
In addition, morphology-based colony selection does not consistently guarantee pluripotent starting populations, since cells can fail to be fully reprogrammed or can naturally differentiate within a colony.
To address this need, R&D Systems offers GloLIVE™ antibodies that allow researchers to confirm stem cell marker expression in live cells before colony selection.
Live pluripotent stem cell imaging:
- Promotes the selection of high quality, undifferentiated stem cell colonies to reduce experimental variation.
- Verifies stem cell pluripotency in 30 minutes, ensuring efficient use of time and reagents.
- Allows for the continued culture of pluripotent cells with no adverse effects on cell proliferation or stemness following staining.
- GloLIVE NL557-conjugated Mouse Anti-Human TRA-1-60(R) Monoclonal Antibody.
- Supplied as 50X concentration of antibody in 0.5 mL PBS
Azide free and endotoxin tested (= 5 EU/mL), this antibody can be used for 12 tests, if a staining volume of 2 mL is used.
TRA-1-60 is a monoclonal antibody raised against a cell surface antigen of human embryonal carcinoma (EC) cells (1). The TRA-1-60 epitope is also found on human embryonic stem (ES) cells and primordial germ cells, and TRA-1-60 serves as a serum marker in patients with germ cell tumors (2‑4). Investigation into the identity of the TRA-1-60 epitope demonstrated that it is a carbohydrate carried by a cell surface, sialylated, keratan sulfate proteoglycan (5). Subsequent evidence implicated podocalyxin as a carrier for the TRA-1-60 epitope (6).
|
Detection of TRA-1-60(R) in Live BG01V Human Embryonic Stem Cells. The stem cell marker TRA-1-60(R) was visualized in live BG01V human embryonic stem cells using a GloLIVE NL557-conjugated Mouse Anti-Human TRA-1-60(R) Monoclonal Antibody (Catalog # NLLC4770R; red). The nuclei were counterstained with Hoechst 33342 (blue). Positive staining for TRA-1-60(R) in human stem cells is an indicator of pluripotency. |
Assay Procedure
Refer to the product datasheet for complete product details.
Precautions
Use aseptic technique and sterile culturing conditions to prevent contamination.
Reagents Provided
GloLIVE NL557-conjugated Mouse Anti-Human TRA-1-60(R) Monoclonal Antibody. (Catalog # NLLC4770R):
Other Supplies Required
Reagents
- Stem cell culture media
Materials
- Human or mouse pluripotent stem cells
- Pipettes and pipette tips
- Serological pipette
Equipment
- 37 °C and 5% CO2 incubator
- Fluorescence microscope
Live Cell Immunocytochemistry Procedure Overview
To ensure sterility of cultures, all steps should be performed under sterile conditions.
- Add fluorochrome-conjugated primary antibody in appropriate culture media to cells.
- Incubate for 30 minutes.
- Replace with fresh culture media.
- Visualize using a fluorescence microscope.
Note: Culture with GloLIVE antibodies does not appear to affect cell proliferation or stemness as assayed by proliferation curves for 3 days post-antibody incubation and expression levels of TRA-1-60(R) and Oct-3/4.